All Stories

  1. Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe
  2. Recurrently affected genes in juvenile myelomonocytic leukaemia
  3. Review: AberrantEVI1expression in acute myeloid leukaemia